BiomerMax-如凤凰

Introduction to BiomerMax

BiomerMax Beauty Equipment Technology (Chengdu) Co., Ltd. (hereinafter referred to as "BiomerMax") was established in August 2019, with the mission of "to pursue the material and spiritual happiness of all partners, provide humans with young skin and anti-aging solutions, and coexist biotechnology with a better life". The vision is to "become a century-old happy enterprise with skin young anti-aging solutions". With a registered capital of 20.41 million yuan, BiomerMax is located in the Tianfu International Bio-town in Chengdu, China. It is a high-tech enterprise, a small and medium-sized enterprise, and the president of procurement and Supply Branch of China Plastic Surgery Association. It is a leading upstream enterprise of medical beauty cultivated in Chengdu, the "capital of medical beauty". BiomerMax is committed to the innovation service of consumer medical supply chain, and lays out the research and development and manufacturing of consumer medical devices supported by the core technology innovation platform of Phoenix recycled materials, so as to build a technology platform company of the whole industry chain integrating research and development, production and supply chain services. The service network covers nearly 700 organizations in 21 cities across the country, and has established the service network of LANCY, ARSMO, MYLIKE,EVERCARE , AIST, YESTAR and other leading groups. The company has developed the country's first yuan universe anti-aging talent "PENNY " with independent intellectual property rights.

Private brand

Bestuneed®Disposable Injection Pack
（Class III Medical Device）

"Bestuneed" is committed to providing the best and highest quality products to meet consumer needs, conveying the brand's pursuit and commitment to quality. "Best" represents the brand's promise of a hundred years of history or long-term existence, emphasizing the brand's stability, reliability, and experience. "Use" indicates that the brand's products have a variety of uses and effects, catering to different needs and expectations. Leveraging high-quality injection needles developed by Condalei, Bestuneed provides consumers with a comprehensive usage experience. The Bestuneed skin channel and other product lines are dedicated to providing exceptional treatment experiences for excellent hospitals and doctors, offering better consumer experiences to those seeking beauty, and fulfilling the mission of "symbiosis of biotechnology and a better life."

Bestuneed®Disposable Injection Pack<span><br />（Class III Medical Device）</span>

Distribution brand

metaverse

微信图片_20240613103804.jpg

With independent intellectual property rights of the country's first yuan universe anti-aging talent "PENNY"

Conference Brand

C37® Supply Chain Conference Platform

BiomerMax innovatively connects groups, medical aesthetic institutions, doctors, consumers, life arts, and social responsibility through a dual-drive strategy of "channel + product" to create solutions for explosive medical aesthetic products. In order to better promote technological innovation and cross-sector connections, and to foster "symbiotic win-win" partnerships, BiomerMax is constructing a "C37" micro-ecosystem based on technological innovation, the Future Research Institute of Fosun, Microsoft China, Pacific Insurance, Machinery Industry Publishing House, China Pharmaceutical Exhibition and the integration of medical aesthetic industry resources. This initiative is guided by the China Society of Plastic Surgery and Aesthetic Medicine Procurement and Supply Branch (CSPSA), and aims to build an industrial ecosystem platform through "value creation" methods such as "technological innovation, cross-sector connections, and industry empowerment". In 2019, in collaboration with more than 20 industry-leading companies such as Huaxi, Haohai, Feidun, Huahan, and Yimeier, the China Society of Plastic Surgery and Aesthetic Medicine Procurement and Supply Branch was established to promote supply chain upgrades, with the goal of building an integrated platform for "government-industry-academia-research-application" in the Chinese medical aesthetic industry and constructing a medical aesthetic industry ecosystem. It has since organized over 20 events, including "C37 Biomer New Momentum" at the Shanghai National Convention Center, "Rushing into Product Innovation and CEO Closed-door Forum on Medical Device Registration System" in Jinxi, "Innovation of Elements in Medical Aesthetic Industrial Park" in Chengdu, and "Cell and Health Industry Forum" in Zhoushan. After the pandemic, it organized more than 30 C37 COO Cloud Forums to assist in the return of medical aesthetic innovation to the normal temperature of 37 degrees Celsius, promoting a healthier and more sustainable business state.

As a promoter of the "National Renowned, Global Leading" "Capital of Medical Aesthetics" initiative by the Chengdu Municipal Government, BiomerMax has been empowering the Chengdu Municipal Government's "Capital of Medical Aesthetics" industry planning, policy consulting, resource integration, and implementation since August 2017. The founder previously served as the Executive Chairman and Secretary-General of the First China International Medical Aesthetics Industry Conference and the Medical Aesthetics Capital Summit Forum in 2018, as well as the Chairman of the Mergers and Acquisitions and Value Investment Forum and the Medical Aesthetics Standardization and Insurance Forum. In 2019, he served as the Chairman of the Second Medical Aesthetics Capital "Product Innovation and Made in China" Forum, the CEO of C37 China Medical Aesthetics, and the Chairman of the Supply Chain Innovation Forum. In 2021, he was the Chairman of the Hainan-China Medical Aesthetics Capital "Chinese Medical Aesthetics CEO" Leadership Forum, dedicated to promoting higher-quality industry development. Representative papers (publications) written, participated in, or led include: "Research and Innovation Exploration in Plastic and Aesthetic Surgery" (Joint Publishing Group of Zhejiang, Zhejiang Science and Technology Press), "Chengdu Medical Aesthetic Industry Development Report (2019)" (Social Science Literature Press), "Chengdu Medical Aesthetic Industry Blue Book (2020)" (in publication), "Chengdu Medical Aesthetic Industry Development Plan (2018-2030)" (government document), "Chengdu Accelerates Support Policies for Medical Aesthetic Industry Development" (government document). He was the principal author of the 2018 Chengdu United Front Work Conference (key research topic in political party consultation) research topic—"Research and Reflections on Accelerating the Development of the Medical Aesthetic Industry and Building the 'Capital of Medical Aesthetics'".